Nearly Nine Years In The Making, AstraZeneca Finally Unveils New Cambridge R&D Hub

Investment In New R&D Technologies

 
• By Andrew McConaghie

After an expensive and protracted construction, AstraZeneca hopes its Cambridge research center will help foster collaboration and extend its run of R&D success.

AstraZeneca's New DISC Building
AstraZeneca's new Discovery Centre in Cambridge (DISC) has been badly delayed and over budget, but is at last in use. • Source: AstraZeneca

More from Business

More from Scrip